If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksExperian Share News (EXPN)

Share Price Information for Experian (EXPN)

Share Price is delayed by 15 minutes
Get Live Data
2,622.00    43.00 (1.67%)
Bid:
2,629.00
Ask:
2,630.00
Spread: 1.00 (0.038%)
Market Cap: £23.30b
EXPN Live PriceLast checked at - London Stock Exchange

Intraday Experian Share Chart

Friday broker round-up

Fri, 15th Nov 2019 13:09
(Sharecast News) - Whitbread: Barclays upgrades to overweight with a target price of 4,900p.

Tyman: Liberum reiterates buy with a target price of 300p.

Experian: Deutsche Bank upgrades to hold with a target price of 2,200p.

Burberry: Deutsche Bank reiterates hold with a target price of 2,010p.

AstraZeneca: Liberum Capital reiterates buy with a target price of 8,250p.

GlaxoSmithKline: Jefferies reiterates buy with a target price of 1,850p.

Workspace: Berenberg downgrades to sell with a target price of 950p.

Berkeley Group: Goldman Sachs downgrades to sell with a target price of 3,860p.

Burberry: Credit Suisse reiterates outperform with a target price of 2,700p.

Genus: Jefferies initiates hold with a target price of 3,272p.

Wetherspoon: Barclays reiterates overweight with a target price of 1,690p.

RHI Magnesita: Barclays reiterates overweight with a target price of 4,400p.

Ted Baker: RBC Capital Markets reiterates sector performer with a target price of 440p

Related News

LONDON MARKET CLOSE: FTSE 100 up as US jobs data eases rate hike fears
5 hours ago

LONDON MARKET CLOSE: FTSE 100 up as US jobs data eases rate hike fears

(Alliance News) - European stocks soared on Thursday as weaker than expected US jobs figures dampened market worries of a near-term interest rate hike...

Hutchmed drug approved in China for advanced gastric cancer
8 hours ago

Hutchmed drug approved in China for advanced gastric cancer

(Alliance News) - Hutchmed China Ltd on Thursday announced regulatory approval for savolitinib, brand name 'ORPATHYS', for a form of gastric cancer wi...

Experian News

EARNINGS AND TRADING: Metals One loss widens as inks Lions Bay deal
2 days ago

EARNINGS AND TRADING: Metals One loss widens as inks Lions Bay deal

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Wednesday and not separately repor...

LONDON MARKET CLOSE: FTSE 100 closes lower as builders, Babcock falter
3 days ago

LONDON MARKET CLOSE: FTSE 100 closes lower as builders, Babcock falter

(Alliance News) - The FTSE 100 ended in the red on Monday as oil prices rose amid renewed tension in the Middle East and housebuilders fell after weak...

LONDON MARKET CLOSE: FTSE 100 dips as bonds struggle after Burnham win
19 Jun 2026

LONDON MARKET CLOSE: FTSE 100 dips as bonds struggle after Burnham win

(Alliance News) - The FTSE 100 ended Friday lower amid domestic political uncertainty and after the postponement of planned US-Iran deal talks in Swit...

IN BRIEF: Experian issues USD1 billion in 10-year bonds at 5.35%
17 Jun 2026

IN BRIEF: Experian issues USD1 billion in 10-year bonds at 5.35%

Experian PLC - Dublin-based provider of consumer credit score checking, fraud detection and credit application processing services - Prices an issue o...

LONDON MARKET CLOSE: FTSE 100 rises but profit warning rocks WH Smith
10 Jun 2026

LONDON MARKET CLOSE: FTSE 100 rises but profit warning rocks WH Smith

(Alliance News) - The FTSE 100 made steady progress on Wednesday, outperforming US and European peers, despite ongoing tension in the Middle East and ...

WINNERS & LOSERS: WH Smith seeks capital, cuts outlook; Workspace down
10 Jun 2026

WINNERS & LOSERS: WH Smith seeks capital, cuts outlook; Workspace down

(Alliance News) - The following are the leading risers and fallers among FTSE 100 and 250 index constituents on Wednesday.